Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
GT Biopharma (OXIA.F) Q3 2025 Earnings
OXIA.F
14
Aug
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-2.56
-1.81
-1.05
-0.29
Details
Expected EPS
-0.5836848
Actual EPS
-0.472098
Surprise EPS
0.11
Surprise Percent
+19.12%
Description
GT Biopharma (OXIA.F) has reported earnings of -0.472098 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login